+Search query
-Structure paper
Title | Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 65, Page 4350-4366, Year 2022 |
Publish date | Sep 20, 2021 (structure data deposition date) |
Authors | Poddutoori, R. / Aardalen, K. / Aithal, K. / Barahagar, S.S. / Belliappa, C. / Bock, M. / Chelur, S. / Gerken, A. / Gopinath, S. / Gruenenfelder, B. ...Poddutoori, R. / Aardalen, K. / Aithal, K. / Barahagar, S.S. / Belliappa, C. / Bock, M. / Chelur, S. / Gerken, A. / Gopinath, S. / Gruenenfelder, B. / Kiffe, M. / Krishnaswami, M. / Langowski, J. / Madapa, S. / Narayanan, K. / Pandit, C. / Panigrahi, S.K. / Perrone, M. / Potakamuri, R.K. / Ramachandra, M. / Ramanathan, A. / Ramos, R. / Sager, E. / Samajdar, S. / Subramanya, H.S. / Thimmasandra, D.S. / Venetsanakos, E. / Mobitz, H. |
External links | J. Med. Chem. / PubMed:35195996 |
Methods | X-ray diffraction |
Resolution | 2.13 Å |
Structure data | PDB-7pqv: |
Chemicals | ChemComp-80C: ChemComp-CA: ChemComp-MG: ChemComp-HOH: |
Source |
|
Keywords | SIGNALING PROTEIN / MEK1 MITOGEN-ACTIVATED PROTEIN KINASE 1 / KINASE INHIBITOR / ANTI-CANCER DRUG |